Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma

International Journal of Cardiovascular Interventions

Volumn 5, Issue 1, 2003, Pages 44-46

  Muir, D F ^b   Stevens, A ^b   Napier Hemy, R O ^a   Fath Ordoubadi, F ^b   Curzen, N ^b  

^a Manchester Heart Centre   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Stent thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN;

ADULT; ANGIOCARDIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; DISEASE ASSOCIATION; DISEASE COURSE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; NEPHRECTOMY; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CARCINOMA, RENAL CELL; CORONARY ANGIOGRAPHY; HUMANS; KIDNEY NEOPLASMS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; NEPHRECTOMY; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STENTS; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037281091     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840304613     Document Type: Article

References (12)

1. Goethals P, Evrard S, Dubois C. Recurrent coronary stent thrombosis. Acta Cardiol 2000; 55: 371-373.
2. Singh B, Isser HS, Sapra R, Sudan D, Kachru R. Coronary stent thrombosis: time course and clinical outcome. Indian Heart J 2000; 52: 554-558.
3. Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombol 2000; 10: 89-101.
4. Schomig A, Neumann F-J, Kastrati A et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089.
5. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH. Double blind study of the safety of clopidogrel with and without loading dose in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000; 102: 624-629.
6. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
7. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularisation. N Engl J Med 1997; 336: 1689-1696.
8. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 1997; 349: 435.
9. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with the use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998; 352: 87-92.
10. Trousseau A. Phlegmasia alba dolens. In: Clinique Medicale de L'Hotel-dieu de Paris, Vol. 3, 2nd edn. París: JB Baillière, 1865.
11. Rigdon EE. Trousseau's syndrome and acute arterial thrombosis. Cardiovasc Surg 2000; 8: 214-218.
12. Sanchez-Ortiz RF, Fraker DL, Malkowicz SB. Renal cell carcinoma presenting with mesenteric thrombosis and anticardiolipin antibodies: echoes of Trousseau's syndrome? J Urol 1998; 159: 2078.